Previous Close | 0.2550 |
Open | 0.2500 |
Bid | 0.2600 x N/A |
Ask | 0.2700 x N/A |
Day's Range | 0.2500 - 0.2700 |
52 Week Range | 0.0900 - 0.7350 |
Volume | |
Avg. Volume | 178,256 |
Market Cap | 14.352M |
Beta (5Y Monthly) | 2.93 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT:93X) (the "Company" or "Promino") is pleased to announce José Bautista will join the firm as a brand ambassador for Promino's patented protein beverages later this year.
Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino") is pleased to announce world-renowned chiropractor, soft tissue specialist and PhD in Neuroscience at Queens University, Dr. Mark Lindsay, one of the most sought-after therapists amongst elite athletes, will join as our corporate advisor focused on professional athletics.
Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT: 93X) (the "Company" or "Promino") is positioned to disrupt the global protein supplement market. The globally patented Promino Plant-Based Blend is shown to be 2x more effective at building muscle than whey protein. Promino products are aligned with the two largest market segments being protein powder and ready-to-drink products.